BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7853749)

  • 1. Inhibition with lactoferrin of in vitro infection with human herpes virus.
    Hasegawa K; Motsuchi W; Tanaka S; Dosako S
    Jpn J Med Sci Biol; 1994 Apr; 47(2):73-85. PubMed ID: 7853749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of lactoferrin against canine herpesvirus.
    Tanaka T; Nakatani S; Xuan X; Kumura H; Igarashi I; Shimazaki Ki
    Antiviral Res; 2003 Nov; 60(3):193-9. PubMed ID: 14638395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells.
    Marchetti M; Longhi C; Conte MP; Pisani S; Valenti P; Seganti L
    Antiviral Res; 1996 Mar; 29(2-3):221-31. PubMed ID: 8739601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro.
    Harmsen MC; Swart PJ; de Béthune MP; Pauwels R; De Clercq E; The TH; Meijer DK
    J Infect Dis; 1995 Aug; 172(2):380-8. PubMed ID: 7622881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
    Ammendolia MG; Marchetti M; Superti F
    Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1.
    Marr AK; Jenssen H; Moniri MR; Hancock RE; Panté N
    Biochimie; 2009 Jan; 91(1):160-4. PubMed ID: 18573311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
    Drobni P; Näslund J; Evander M
    Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of ovotransferrin discloses an evolutionary strategy for the defensive activities of lactoferrin.
    Giansanti F; Rossi P; Massucci MT; Botti D; Antonini G; Valenti P; Seganti L
    Biochem Cell Biol; 2002; 80(1):125-30. PubMed ID: 11908636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activities against HSV-1, HCMV, and HIV-1 of rhamnan sulfate from Monostroma latissimum.
    Lee JB; Hayashi K; Hayashi T; Sankawa U; Maeda M
    Planta Med; 1999 Jun; 65(5):439-41. PubMed ID: 10418331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin. Antiviral activity of lactoferrin.
    Swart PJ; Kuipers EM; Smit C; Van Der Strate BW; Harmsen MC; Meijer DK
    Adv Exp Med Biol; 1998; 443():205-13. PubMed ID: 9781360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
    Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
    Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2.
    Marchetti M; Pisani S; Antonini G; Valenti P; Seganti L; Orsi N
    Biometals; 1998 Apr; 11(2):89-94. PubMed ID: 9542061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenoxazine derivatives inactivate human cytomegalovirus, herpes simplex virus-1, and herpes simplex virus-2 in vitro.
    Hayashi K; Hayashi T; Tomoda A
    J Pharmacol Sci; 2008 Mar; 106(3):369-75. PubMed ID: 18319567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
    Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin.
    Marchetti M; Ammendolia MG; Superti F
    Biochimie; 2009 Jan; 91(1):155-9. PubMed ID: 18534197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea.
    Fujihara T; Hayashi K
    Arch Virol; 1995; 140(8):1469-72. PubMed ID: 7661698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
    Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
    Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection.
    Siciliano R; Rega B; Marchetti M; Seganti L; Antonini G; Valenti P
    Biochem Biophys Res Commun; 1999 Oct; 264(1):19-23. PubMed ID: 10527833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice.
    Wakabayashi H; Kurokawa M; Shin K; Teraguchi S; Tamura Y; Shiraki K
    Biosci Biotechnol Biochem; 2004 Mar; 68(3):537-44. PubMed ID: 15056884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.